BetterLife Pharma Inc. Stock Canadian Securities Exchange
Equities
BETR
CA08772P2026
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | 0.00% | -3.85% | +108.33% |
05-14 | BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001 | CI |
05-03 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 18.14M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.35M | Net income 2023 | -9M -12.26M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 189K | Net Debt 2023 | 71.69K 97.65K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
1 week | -3.85% | ||
Current month | +8.70% | ||
1 month | +25.00% | ||
3 months | +47.06% | ||
6 months | +108.33% | ||
Current year | +108.33% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.125 | 0.00% | 13,220 |
24-05-14 | 0.125 | +4.17% | 67,500 |
24-05-13 | 0.12 | -4.00% | 24,056 |
24-05-10 | 0.125 | -3.85% | 12,750 |
24-05-08 | 0.13 | 0.00% | 128,250 |
Delayed Quote Canadian Securities Exchange, May 15, 2024 at 10:50 am
More quotes1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
+0.82% | 22.27B | |
-12.64% | 22.22B | |
-4.50% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- BETRF Stock
- BETR Stock